| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2559 | |||||||||||||||||||||||
| Submitter : | Mrs. Jennifer Donovan | Date & Time: | 12/05/2006 10:12:20 | |||||||||||||||||||||
| Organization : | Mrs. Jennifer Donovan | |||||||||||||||||||||||
| Category : | Drug Industry | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| To whom it may concern,
Please cease the use of aborted fetal cell lines for the creation of vaccinations. They are unethical and other options are available. Human tissue is not a commodity to be used for profit. Sincerely, Jennifer Donovan | ||||||||||||||||||||||||